Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a condition where more hair than usual falls out after stress or fever.

Telogen effluvium is a common hair loss where hair sheds due to stress but new hair still grows.

Sandalore, a synthetic scent, was found to reduce hair loss and improve hair growth in women with hair shedding issues.

Sandalore® reduces hair shedding and increases hair volume in women with telogen effluvium.

Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

Postpartum hair loss usually stops within 4-6 months.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Yellow dots look different in various hair loss conditions and can help diagnose them.

The Epilight Hair Removal System is effective for temporary hair removal with few side effects, but more research is needed to confirm its safety and long-term results.

Eating more protein during weight loss can prevent hair loss caused by not having enough protein.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Early shedding of the inner root sheath in noninflamed hair follicles is a relatively specific sign of Central Centrifugal Cicatricial Alopecia.

Teledermatology can effectively diagnose Loose Anagen Syndrome remotely.

Haarpower® did not significantly reduce excessive shedding in dogs.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Oral contraceptives may cause hair loss in women.

The study concluded that neonatal occipital alopecia is common, not caused by physical friction, and usually resolves on its own without treatment.

Some people with chronic hair loss may have thyroid autoimmunity.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.